Refine your search:     
Report No.
 - 
Search Results: Records 1-5 displayed on this page of 5
  • 1

Presentation/Publication Type

Initialising ...

Refine

Journal/Book Title

Initialising ...

Meeting title

Initialising ...

First Author

Initialising ...

Keyword

Initialising ...

Language

Initialising ...

Publication Year

Initialising ...

Held year of conference

Initialising ...

Save select records

Journal Articles

Why ion beam now; New development of application study of radiations

Tanaka, Ryuichi; Matsuda, Sumio*; Watanabe, Hiroshi; Naramoto, Hiroshi

Koatsu Gasu, 31(10), p.754 - 776, 1994/00

no abstracts in English

Journal Articles

Outline of TIARA

Tanaka, Ryuichi

Hoshasen To Sangyo, (52), p.34 - 39, 1991/12

no abstracts in English

Journal Articles

Ion beam application plan in JAERI, Takasaki

Tanaka, Ryuichi

Nihon Genshiryoku Gakkai-Shi, 33(11), p.1018 - 1023, 1991/11

no abstracts in English

Journal Articles

Takasaki ion accelerators for advanced radiation application

Tanaka, Ryuichi

Proceedings of 4th China-Japan Joint Symposium on Accelerators for Nuclear Science and their Applications, p.127 - 130, 1991/00

no abstracts in English

Oral presentation

Production of alpha-emitting radioisotopes using the cyclotron facilities at Osaka University and JAEA Takasaki, and the Tandem accelerator at Tokai, JAEA

Washiyama, Koshin*; Amano, Ryohei*; Maeda, Eita*; Yokoyama, Akihiko*; Nishinaka, Ichiro; Takahashi, Naruto*; Shinohara, Atsushi*; Watanabe, Shigeki; Ishioka, Noriko

no journal, , 

In order to use of an alpha emitter for targeted alpha therapy, we have started the production and the utilization of $$^{211}$$At using 30 MeV $$^4$$He particle in the $$^{209}$$Bi($$^4$$He, 2n)$$^{211}$$At nuclear reaction at cyclotron facilities of Osaka University and JAEA Takasaki. In addition to that, we have been developing a $$^{211}$$Rn/$$^{211}$$At generator to expand the availability of $$^{211}$$At to wide range of populations far away from cyclotron facilities. The results of studies on the At-chemistry for clinical use and on the development of the $$^{211}$$Rn/$$^{211}$$At generator will be presented. And a review of current status of targeted alpha therapy in Japan will be also introduced.

5 (Records 1-5 displayed on this page)
  • 1